Study to Assess Effect of HFO MDI Propellant on Mucociliary Clearance Compared to HFA MDI Propellant in Healthy Participants

Trial Identifier: D5985C00006
Sponsor: AstraZeneca
NCTID:: NCT05755932
Start Date: June 2023
Primary Completion Date: July 2024
Study Completion Date: July 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA San Diego, CA, US, 92103
US, CA Stanford, CA, US, 94305
US, KS Kansas City, KS, US, 66160
US, MD Baltimore, MD, US, 21287
US, NC Chapel Hill, NC, US, 27599
US, PA Pittsburgh, PA, US, 15213